APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oxycodone Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oxycodone Hydrochloride Injection Market Analysis and Forecast 2026-2032

Report ID 174021550227 December 2025190 pages

Choose your research edition.

Industry ResearchOxycodone Hydrochloride Injection Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxycodone Hydrochloride Injection Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Oxycodone Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxycodone Hydrochloride Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxycodone Hydrochloride Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Oxycodone Hydrochloride Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Oxycodone Hydrochloride Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oxycodone Hydrochloride Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oxycodone Hydrochloride Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oxycodone Hydrochloride Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Oxycodone Hydrochloride Injection include LTL Pharma Co., Ltd., NAPP PHARMACEUTICALS LIMITED, Organon LLC, Sumitomo Pharma America, Inc., Teva Takeda Yakuhin Ltd., Santen Pharmaceutical Co.,Ltd., Hengrui Medicine, Mylan Pharmaceuticals and Teva Pharmaceutical Industries, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Oxycodone Hydrochloride Injection, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oxycodone Hydrochloride Injection, also provides the revenue of main regions and countries. Of the upcoming market potential for Oxycodone Hydrochloride Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oxycodone Hydrochloride Injection revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oxycodone Hydrochloride Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Oxycodone Hydrochloride Injection revenue, projected growth trends, production technology, application and end-user industry.

Oxycodone Hydrochloride Injection Segment by Company

LTL Pharma Co., Ltd.

NAPP PHARMACEUTICALS LIMITED

Organon LLC

Sumitomo Pharma America, Inc.

Teva Takeda Yakuhin Ltd.

Santen Pharmaceutical Co.,Ltd.

Hengrui Medicine

Mylan Pharmaceuticals

Teva Pharmaceutical Industries

Oxycodone Hydrochloride Injection Segment by Type

2ml:20mg

1ml:10mg

Oxycodone Hydrochloride Injection Segment by Application

Hospital

Clinic

Others

Oxycodone Hydrochloride Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Oxycodone Hydrochloride Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Oxycodone Hydrochloride Injection company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oxycodone Hydrochloride Injection revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oxycodone Hydrochloride Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 2ml:20mg Major Player Table 3. 1ml:10mg Major Player Table 4. Global Oxycodone Hydrochloride Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Others Major Player Table 8. Oxycodone Hydrochloride Injection Industry Trends Table 9. Oxycodone Hydrochloride Injection Industry Drivers Table 10. Oxycodone Hydrochloride Injection Industry Opportunities and Challenges Table 11. Oxycodone Hydrochloride Injection Industry Restraints Table 12. Global Oxycodone Hydrochloride Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Oxycodone Hydrochloride Injection Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Oxycodone Hydrochloride Injection Market Share by Region (2021-2026) Table 15. Global Oxycodone Hydrochloride Injection Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Oxycodone Hydrochloride Injection Market Share by Region (2027-2032) Table 17. Global Oxycodone Hydrochloride Injection Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Oxycodone Hydrochloride Injection Revenue Market Share by Players (2021-2026) Table 19. Global Oxycodone Hydrochloride Injection Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Oxycodone Hydrochloride Injection Key Players Headquarters & Area Served Table 21. Global Oxycodone Hydrochloride Injection Players, Product Type & Application Table 22. Global Oxycodone Hydrochloride Injection Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Oxycodone Hydrochloride Injection by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Oxycodone Hydrochloride Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Oxycodone Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Oxycodone Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Oxycodone Hydrochloride Injection Revenue Market Share by Type (2021-2026) Table 29. Global Oxycodone Hydrochloride Injection Revenue Market Share by Type (2027-2032) Table 30. Global Oxycodone Hydrochloride Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Oxycodone Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Oxycodone Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Oxycodone Hydrochloride Injection Revenue Market Share by Application (2021-2026) Table 34. Global Oxycodone Hydrochloride Injection Revenue Market Share by Application (2027-2032) Table 35. LTL Pharma Co., Ltd. Company Information Table 36. LTL Pharma Co., Ltd. Business Overview Table 37. LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Product Portfolio Table 39. LTL Pharma Co., Ltd. Recent Development Table 40. NAPP PHARMACEUTICALS LIMITED Company Information Table 41. NAPP PHARMACEUTICALS LIMITED Business Overview Table 42. NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Product Portfolio Table 44. NAPP PHARMACEUTICALS LIMITED Recent Development Table 45. Organon LLC Company Information Table 46. Organon LLC Business Overview Table 47. Organon LLC Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Organon LLC Oxycodone Hydrochloride Injection Product Portfolio Table 49. Organon LLC Recent Development Table 50. Sumitomo Pharma America, Inc. Company Information Table 51. Sumitomo Pharma America, Inc. Business Overview Table 52. Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Product Portfolio Table 54. Sumitomo Pharma America, Inc. Recent Development Table 55. Teva Takeda Yakuhin Ltd. Company Information Table 56. Teva Takeda Yakuhin Ltd. Business Overview Table 57. Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Product Portfolio Table 59. Teva Takeda Yakuhin Ltd. Recent Development Table 60. Santen Pharmaceutical Co.,Ltd. Company Information Table 61. Santen Pharmaceutical Co.,Ltd. Business Overview Table 62. Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Product Portfolio Table 64. Santen Pharmaceutical Co.,Ltd. Recent Development Table 65. Hengrui Medicine Company Information Table 66. Hengrui Medicine Business Overview Table 67. Hengrui Medicine Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Hengrui Medicine Oxycodone Hydrochloride Injection Product Portfolio Table 69. Hengrui Medicine Recent Development Table 70. Mylan Pharmaceuticals Company Information Table 71. Mylan Pharmaceuticals Business Overview Table 72. Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Product Portfolio Table 74. Mylan Pharmaceuticals Recent Development Table 75. Teva Pharmaceutical Industries Company Information Table 76. Teva Pharmaceutical Industries Business Overview Table 77. Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Product Portfolio Table 79. Teva Pharmaceutical Industries Recent Development Table 80. North America Oxycodone Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 81. North America Oxycodone Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 82. North America Oxycodone Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Oxycodone Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Oxycodone Hydrochloride Injection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Oxycodone Hydrochloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Oxycodone Hydrochloride Injection Revenue by Country (US$ Million) & (2027-2032) Table 87. Europe Oxycodone Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 88. Europe Oxycodone Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 89. Europe Oxycodone Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 90. Europe Oxycodone Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 91. Europe Oxycodone Hydrochloride Injection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Oxycodone Hydrochloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 93. Europe Oxycodone Hydrochloride Injection Revenue by Country (US$ Million) & (2027-2032) Table 94. China Oxycodone Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 95. China Oxycodone Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 96. China Oxycodone Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 97. China Oxycodone Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Oxycodone Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 99. Asia Oxycodone Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 100. Asia Oxycodone Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 101. Asia Oxycodone Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Oxycodone Hydrochloride Injection Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Oxycodone Hydrochloride Injection Revenue by Region (US$ Million) & (2021-2026) Table 104. Asia Oxycodone Hydrochloride Injection Revenue by Region (US$ Million) & (2027-2032) Table 105. SAMEA Oxycodone Hydrochloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 106. SAMEA Oxycodone Hydrochloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 107. SAMEA Oxycodone Hydrochloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 108. SAMEA Oxycodone Hydrochloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 109. SAMEA Oxycodone Hydrochloride Injection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. SAMEA Oxycodone Hydrochloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 111. SAMEA Oxycodone Hydrochloride Injection Revenue by Country (US$ Million) & (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Oxycodone Hydrochloride Injection Image Figure 2. Global Oxycodone Hydrochloride Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxycodone Hydrochloride Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 2ml:20mg Image Figure 5. 1ml:10mg Image Figure 6. Global Oxycodone Hydrochloride Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Oxycodone Hydrochloride Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Oxycodone Hydrochloride Injection Market Size (US$ Million) & (2021-2032) Figure 12. Global Oxycodone Hydrochloride Injection Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Oxycodone Hydrochloride Injection Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Oxycodone Hydrochloride Injection Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Oxycodone Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Oxycodone Hydrochloride Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Oxycodone Hydrochloride Injection Revenue Market Share by Type (2021-2032) Figure 19. Global Oxycodone Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Oxycodone Hydrochloride Injection Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Oxycodone Hydrochloride Injection Revenue Market Share by Application (2021-2032) Figure 22. North America Oxycodone Hydrochloride Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Oxycodone Hydrochloride Injection Revenue Share by Type (2021-2032) Figure 24. North America Oxycodone Hydrochloride Injection Revenue Share by Application (2021-2032) Figure 25. North America Oxycodone Hydrochloride Injection Revenue Share by Country (2021-2032) Figure 26. United States Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Oxycodone Hydrochloride Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Oxycodone Hydrochloride Injection Revenue Share by Type (2021-2032) Figure 31. Europe Oxycodone Hydrochloride Injection Revenue Share by Application (2021-2032) Figure 32. Europe Oxycodone Hydrochloride Injection Revenue Share by Country (2021-2032) Figure 33. Germany Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Oxycodone Hydrochloride Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Oxycodone Hydrochloride Injection Revenue Share by Type (2021-2032) Figure 43. China Oxycodone Hydrochloride Injection Revenue Share by Application (2021-2032) Figure 44. Asia Oxycodone Hydrochloride Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Oxycodone Hydrochloride Injection Revenue Share by Type (2021-2032) Figure 46. Asia Oxycodone Hydrochloride Injection Revenue Share by Application (2021-2032) Figure 47. Asia Oxycodone Hydrochloride Injection Revenue Share by Region (2021-2032) Figure 48. Japan Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Oxycodone Hydrochloride Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Oxycodone Hydrochloride Injection Revenue Share by Type (2021-2032) Figure 56. SAMEA Oxycodone Hydrochloride Injection Revenue Share by Application (2021-2032) Figure 57. SAMEA Oxycodone Hydrochloride Injection Revenue Share by Country (2021-2032) Figure 58. Brazil Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Oxycodone Hydrochloride Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 2ml:20mg
  • 1ml:10mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • LTL Pharma Co., Ltd.
  • NAPP PHARMACEUTICALS LIMITED
  • Organon LLC
  • Sumitomo Pharma America, Inc.
  • Teva Takeda Yakuhin Ltd.
  • Santen Pharmaceutical Co.,Ltd.
  • Hengrui Medicine
  • Mylan Pharmaceuticals
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oxycodone Hydrochloride Injection Market by Type
  3. 1.2.1 Global Oxycodone Hydrochloride Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 2ml:20mg
  5. 1.2.3 1ml:10mg
  6. 1.3 Oxycodone Hydrochloride Injection Market by Application
  7. 1.3.1 Global Oxycodone Hydrochloride Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Oxycodone Hydrochloride Injection Market Dynamics
  1. 2.1 Oxycodone Hydrochloride Injection Industry Trends
  2. 2.2 Oxycodone Hydrochloride Injection Industry Drivers
  3. 2.3 Oxycodone Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Oxycodone Hydrochloride Injection Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Oxycodone Hydrochloride Injection Market Perspective (2021-2032)
  2. 3.2 Global Oxycodone Hydrochloride Injection Growth Trends by Region
  3. 3.2.1 Global Oxycodone Hydrochloride Injection Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oxycodone Hydrochloride Injection Market Size by Region (2021-2026)
  5. 3.2.3 Global Oxycodone Hydrochloride Injection Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Oxycodone Hydrochloride Injection Revenue by Players
  2. 4.1.1 Global Oxycodone Hydrochloride Injection Revenue by Players (2021-2026)
  3. 4.1.2 Global Oxycodone Hydrochloride Injection Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Oxycodone Hydrochloride Injection Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oxycodone Hydrochloride Injection Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Oxycodone Hydrochloride Injection Key Players Headquarters & Area Served
  7. 4.4 Global Oxycodone Hydrochloride Injection Players, Product Type & Application
  8. 4.5 Global Oxycodone Hydrochloride Injection Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Oxycodone Hydrochloride Injection Market CR5 and HHI
  11. 4.6.3 2025 Oxycodone Hydrochloride Injection Tier 1, Tier 2, and Tier 3
5 Oxycodone Hydrochloride Injection Market Size by Type
  1. 5.1 Global Oxycodone Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Oxycodone Hydrochloride Injection Revenue by Type (2021-2032)
  3. 5.3 Global Oxycodone Hydrochloride Injection Revenue Market Share by Type (2021-2032)
6 Oxycodone Hydrochloride Injection Market Size by Application
  1. 6.1 Global Oxycodone Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Oxycodone Hydrochloride Injection Revenue by Application (2021-2032)
  3. 6.3 Global Oxycodone Hydrochloride Injection Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 LTL Pharma Co., Ltd.
  2. 7.1.1 LTL Pharma Co., Ltd. Company Information
  3. 7.1.2 LTL Pharma Co., Ltd. Business Overview
  4. 7.1.3 LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Revenue and Gross Margin (2021-2026)
  5. 7.1.4 LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Product Portfolio
  6. 7.1.5 LTL Pharma Co., Ltd. Recent Developments
  7. 7.2 NAPP PHARMACEUTICALS LIMITED
  8. 7.2.1 NAPP PHARMACEUTICALS LIMITED Company Information
  9. 7.2.2 NAPP PHARMACEUTICALS LIMITED Business Overview
  10. 7.2.3 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Revenue and Gross Margin (2021-2026)
  11. 7.2.4 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Product Portfolio
  12. 7.2.5 NAPP PHARMACEUTICALS LIMITED Recent Developments
  13. 7.3 Organon LLC
  14. 7.3.1 Organon LLC Company Information
  15. 7.3.2 Organon LLC Business Overview
  16. 7.3.3 Organon LLC Oxycodone Hydrochloride Injection Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Organon LLC Oxycodone Hydrochloride Injection Product Portfolio
  18. 7.3.5 Organon LLC Recent Developments
  19. 7.4 Sumitomo Pharma America, Inc.
  20. 7.4.1 Sumitomo Pharma America, Inc. Company Information
  21. 7.4.2 Sumitomo Pharma America, Inc. Business Overview
  22. 7.4.3 Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Product Portfolio
  24. 7.4.5 Sumitomo Pharma America, Inc. Recent Developments
  25. 7.5 Teva Takeda Yakuhin Ltd.
  26. 7.5.1 Teva Takeda Yakuhin Ltd. Company Information
  27. 7.5.2 Teva Takeda Yakuhin Ltd. Business Overview
  28. 7.5.3 Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Product Portfolio
  30. 7.5.5 Teva Takeda Yakuhin Ltd. Recent Developments
  31. 7.6 Santen Pharmaceutical Co.,Ltd.
  32. 7.6.1 Santen Pharmaceutical Co.,Ltd. Company Information
  33. 7.6.2 Santen Pharmaceutical Co.,Ltd. Business Overview
  34. 7.6.3 Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Product Portfolio
  36. 7.6.5 Santen Pharmaceutical Co.,Ltd. Recent Developments
  37. 7.7 Hengrui Medicine
  38. 7.7.1 Hengrui Medicine Company Information
  39. 7.7.2 Hengrui Medicine Business Overview
  40. 7.7.3 Hengrui Medicine Oxycodone Hydrochloride Injection Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Hengrui Medicine Oxycodone Hydrochloride Injection Product Portfolio
  42. 7.7.5 Hengrui Medicine Recent Developments
  43. 7.8 Mylan Pharmaceuticals
  44. 7.8.1 Mylan Pharmaceuticals Company Information
  45. 7.8.2 Mylan Pharmaceuticals Business Overview
  46. 7.8.3 Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Product Portfolio
  48. 7.8.5 Mylan Pharmaceuticals Recent Developments
  49. 7.9 Teva Pharmaceutical Industries
  50. 7.9.1 Teva Pharmaceutical Industries Company Information
  51. 7.9.2 Teva Pharmaceutical Industries Business Overview
  52. 7.9.3 Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Product Portfolio
  54. 7.9.5 Teva Pharmaceutical Industries Recent Developments
8 North America
  1. 8.1 North America Oxycodone Hydrochloride Injection Revenue (2021-2032)
  2. 8.2 North America Oxycodone Hydrochloride Injection Revenue by Type (2021-2032)
  3. 8.2.1 North America Oxycodone Hydrochloride Injection Revenue by Type (2021-2026)
  4. 8.2.2 North America Oxycodone Hydrochloride Injection Revenue by Type (2027-2032)
  5. 8.3 North America Oxycodone Hydrochloride Injection Revenue Share by Type (2021-2032)
  6. 8.4 North America Oxycodone Hydrochloride Injection Revenue by Application (2021-2032)
  7. 8.4.1 North America Oxycodone Hydrochloride Injection Revenue by Application (2021-2026)
  8. 8.4.2 North America Oxycodone Hydrochloride Injection Revenue by Application (2027-2032)
  9. 8.5 North America Oxycodone Hydrochloride Injection Revenue Share by Application (2021-2032)
  10. 8.6 North America Oxycodone Hydrochloride Injection Revenue by Country
  11. 8.6.1 North America Oxycodone Hydrochloride Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Oxycodone Hydrochloride Injection Revenue by Country (2021-2026)
  13. 8.6.3 North America Oxycodone Hydrochloride Injection Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Oxycodone Hydrochloride Injection Revenue (2021-2032)
  2. 9.2 Europe Oxycodone Hydrochloride Injection Revenue by Type (2021-2032)
  3. 9.2.1 Europe Oxycodone Hydrochloride Injection Revenue by Type (2021-2026)
  4. 9.2.2 Europe Oxycodone Hydrochloride Injection Revenue by Type (2027-2032)
  5. 9.3 Europe Oxycodone Hydrochloride Injection Revenue Share by Type (2021-2032)
  6. 9.4 Europe Oxycodone Hydrochloride Injection Revenue by Application (2021-2032)
  7. 9.4.1 Europe Oxycodone Hydrochloride Injection Revenue by Application (2021-2026)
  8. 9.4.2 Europe Oxycodone Hydrochloride Injection Revenue by Application (2027-2032)
  9. 9.5 Europe Oxycodone Hydrochloride Injection Revenue Share by Application (2021-2032)
  10. 9.6 Europe Oxycodone Hydrochloride Injection Revenue by Country
  11. 9.6.1 Europe Oxycodone Hydrochloride Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Oxycodone Hydrochloride Injection Revenue by Country (2021-2026)
  13. 9.6.3 Europe Oxycodone Hydrochloride Injection Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Oxycodone Hydrochloride Injection Revenue (2021-2032)
  2. 10.2 China Oxycodone Hydrochloride Injection Revenue by Type (2021-2032)
  3. 10.2.1 China Oxycodone Hydrochloride Injection Revenue by Type (2021-2026)
  4. 10.2.2 China Oxycodone Hydrochloride Injection Revenue by Type (2027-2032)
  5. 10.3 China Oxycodone Hydrochloride Injection Revenue Share by Type (2021-2032)
  6. 10.4 China Oxycodone Hydrochloride Injection Revenue by Application (2021-2032)
  7. 10.4.1 China Oxycodone Hydrochloride Injection Revenue by Application (2021-2026)
  8. 10.4.2 China Oxycodone Hydrochloride Injection Revenue by Application (2027-2032)
  9. 10.5 China Oxycodone Hydrochloride Injection Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oxycodone Hydrochloride Injection Revenue (2021-2032)
  2. 11.2 Asia Oxycodone Hydrochloride Injection Revenue by Type (2021-2032)
  3. 11.2.1 Asia Oxycodone Hydrochloride Injection Revenue by Type (2021-2026)
  4. 11.2.2 Asia Oxycodone Hydrochloride Injection Revenue by Type (2027-2032)
  5. 11.3 Asia Oxycodone Hydrochloride Injection Revenue Share by Type (2021-2032)
  6. 11.4 Asia Oxycodone Hydrochloride Injection Revenue by Application (2021-2032)
  7. 11.4.1 Asia Oxycodone Hydrochloride Injection Revenue by Application (2021-2026)
  8. 11.4.2 Asia Oxycodone Hydrochloride Injection Revenue by Application (2027-2032)
  9. 11.5 Asia Oxycodone Hydrochloride Injection Revenue Share by Application (2021-2032)
  10. 11.6 Asia Oxycodone Hydrochloride Injection Revenue by Country
  11. 11.6.1 Asia Oxycodone Hydrochloride Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Oxycodone Hydrochloride Injection Revenue by Country (2021-2026)
  13. 11.6.3 Asia Oxycodone Hydrochloride Injection Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oxycodone Hydrochloride Injection Revenue (2021-2032)
  2. 12.2 SAMEA Oxycodone Hydrochloride Injection Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Oxycodone Hydrochloride Injection Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Oxycodone Hydrochloride Injection Revenue by Type (2027-2032)
  5. 12.3 SAMEA Oxycodone Hydrochloride Injection Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Oxycodone Hydrochloride Injection Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Oxycodone Hydrochloride Injection Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Oxycodone Hydrochloride Injection Revenue by Application (2027-2032)
  9. 12.5 SAMEA Oxycodone Hydrochloride Injection Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Oxycodone Hydrochloride Injection Revenue by Country
  11. 12.6.1 SAMEA Oxycodone Hydrochloride Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Oxycodone Hydrochloride Injection Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Oxycodone Hydrochloride Injection Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst